Brazil · Delayed Price · Currency is BRL Medtronic Statistics
Total Valuation
Medtronic has a market cap or net worth of BRL 584.63 billion. The enterprise value is 689.04 billion.
| Market Cap | 584.63B |
| Enterprise Value | 689.04B |
Important Dates
The next confirmed earnings date is Wednesday, May 20, 2026.
| Earnings Date | May 20, 2026 |
| Ex-Dividend Date | Dec 23, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.83% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 0.05% |
| Owned by Institutions (%) | 87.13% |
| Float | 1.28B |
Valuation Ratios
The trailing PE ratio is 23.95 and the forward PE ratio is 14.49.
| PE Ratio | 23.95 |
| Forward PE | 14.49 |
| PS Ratio | 3.11 |
| PB Ratio | 2.25 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 20.42 |
| P/OCF Ratio | 15.17 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.39, with an EV/FCF ratio of 24.07.
| EV / Earnings | 28.23 |
| EV / Sales | 3.67 |
| EV / EBITDA | 13.39 |
| EV / EBIT | 19.66 |
| EV / FCF | 24.07 |
Financial Position
The company has a current ratio of 2.54, with a Debt / Equity ratio of 0.57.
| Current Ratio | 2.54 |
| Quick Ratio | 1.55 |
| Debt / Equity | 0.57 |
| Debt / EBITDA | 2.88 |
| Debt / FCF | 5.19 |
| Interest Coverage | 9.30 |
Financial Efficiency
Return on equity (ROE) is 9.39% and return on invested capital (ROIC) is 7.98%.
| Return on Equity (ROE) | 9.39% |
| Return on Assets (ROA) | 4.57% |
| Return on Invested Capital (ROIC) | 7.98% |
| Return on Capital Employed (ROCE) | 8.09% |
| Weighted Average Cost of Capital (WACC) | 7.02% |
| Revenue Per Employee | 1.98M |
| Profits Per Employee | 256,925 |
| Employee Count | 95,000 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 2.07 |
Taxes
In the past 12 months, Medtronic has paid 4.88 billion in taxes.
| Income Tax | 4.88B |
| Effective Tax Rate | 16.59% |
Stock Price Statistics
The stock price has decreased by -12.24% in the last 52 weeks. The beta is 0.73, so Medtronic's price volatility has been lower than the market average.
| Beta (5Y) | 0.73 |
| 52-Week Price Change | -12.24% |
| 50-Day Moving Average | 255.99 |
| 200-Day Moving Average | 242.55 |
| Relative Strength Index (RSI) | 29.76 |
| Average Volume (20 Days) | 89 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.92 |
Income Statement
In the last 12 months, Medtronic had revenue of BRL 187.75 billion and earned 24.41 billion in profits. Earnings per share was 18.94.
| Revenue | 187.75B |
| Gross Profit | 122.34B |
| Operating Income | 35.08B |
| Pretax Income | 29.43B |
| Net Income | 24.41B |
| EBITDA | 49.95B |
| EBIT | 35.08B |
| Earnings Per Share (EPS) | 18.94 |
Balance Sheet
The company has 44.36 billion in cash and 148.53 billion in debt, with a net cash position of -103.41 billion.
| Cash & Cash Equivalents | 44.36B |
| Total Debt | 148.53B |
| Net Cash | -103.41B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 260.30B |
| Book Value Per Share | 201.96 |
| Working Capital | 77.12B |
Cash Flow
In the last 12 months, operating cash flow was 38.55 billion and capital expenditures -9.92 billion, giving a free cash flow of 28.62 billion.
| Operating Cash Flow | 38.55B |
| Capital Expenditures | -9.92B |
| Depreciation & Amortization | 14.93B |
| Net Borrowing | -5.37B |
| Free Cash Flow | 28.62B |
| FCF Per Share | n/a |
Margins
Gross margin is 65.16%, with operating and profit margins of 18.68% and 13.00%.
| Gross Margin | 65.16% |
| Operating Margin | 18.68% |
| Pretax Margin | 15.67% |
| Profit Margin | 13.00% |
| EBITDA Margin | 26.60% |
| EBIT Margin | 18.68% |
| FCF Margin | 15.25% |
Dividends & Yields
This stock pays an annual dividend of 5.68, which amounts to a dividend yield of 2.44%.
| Dividend Per Share | 5.68 |
| Dividend Yield | 2.44% |
| Dividend Growth (YoY) | 0.43% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 78.65% |
| Buyback Yield | 0.83% |
| Shareholder Yield | 3.26% |
| Earnings Yield | 4.17% |
| FCF Yield | 4.90% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Medtronic has an Altman Z-Score of 2.98 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.98 |
| Piotroski F-Score | 6 |